)
MEDS Apotek (MEDS) investor relations material
MEDS Apotek Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 net sales fell 5.9% YoY as warehouse relocation and longer-than-planned staff training constrained capacity; July–August sales grew 19% YoY with adjusted EBIT margin of 3.3%.
For 9M, net sales grew 7.8% and EBIT returned to profit; the new Eskilstuna logistics centre was commissioned, with delivery times normalised during October.
Financial highlights
Q3 net sales were SEK 233.9M versus SEK 248.6M; gross profit was SEK 65.3M versus SEK 68.4M, and net income was -SEK 4.9M versus -SEK 5.8M.
9M net sales were SEK 807.4M versus SEK 748.7M; net income was SEK 6.0M versus a SEK 2.1M loss.
Q3 adjusted EBIT was SEK 1.1M versus SEK 4.9M; 9M adjusted EBIT was SEK 12.3M versus SEK 14.7M, including relocation-related comparability items.
Outlook and guidance
Targets: triple organic net sales within 5–6 years and achieve a 3–5% operating margin in the short to medium term.
Q4 priorities are to stabilise and optimise logistics operations and ensure high delivery capacity ahead of 2027; management expects cash flow to gradually normalise.
The online pharmacy market is expected to grow; Q4 is usually one of the strongest sales quarters.
- Q2 2026 net sales up 18%, EBIT up 38%, with strong RX/OTC growth and logistics move impact.MEDS
Q2 2026 - Q1 2026 saw 12% sales growth, 34% RX sales surge, and logistics expansion investment ahead.MEDS
Q1 2026 - Record SEK 1 billion sales, strong Rx growth, and expanded logistics drive future growth.MEDS
Q4 2025 - Rapid market share growth, strong financials, and tech-driven scalability position for continued expansion.MEDS
ABGSC Investor Days - Q3 sales up 22%, RX up 52%, IPO raised 70 MSEK, and profitability improved.MEDS
Q3 2025 - Revenue up 27% to SEK 837.4m, losses narrowed, and Q4 turned positive.MEDS
Q4 2024
Next MEDS Apotek earnings date
Next MEDS Apotek earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)